Literature DB >> 22262124

Validation study of the Italian Addenbrooke's Cognitive Examination Revised in a young-old and old-old population.

M Pigliautile1, M Ricci, E Mioshi, S Ercolani, F Mangialasche, R Monastero, M F Croce, S Federici, P Mecocci.   

Abstract

AIMS: The main aims of the study were the translation and the subsequent validation in Italian of the Addenbrooke's Cognitive Examination Revised (ACE-R), and the evaluation of its usefulness in discriminating cognitively normal subjects from patients with mild dementia in an elderly population.
METHODS: The ACE-R was translated and adapted into Italian. The Italian ACE-R was administered to a group of 179 elderly subjects (72 cognitively healthy and 107 subjects with mild dementia, mean age 75.4±6.4 years). The group was stratified into two subsamples according to age, i.e. a young-old (<75 years) and an old-old (≥75 years) group, in order to evaluate the sensitivity and specificity of the test in detecting dementia in different age strata of elderly subjects.
RESULTS: The reliability of the Italian ACE-R was extremely good (α-coefficient=0.85). Two different cutoffs were identified for young-old (cutoff 79; sensitivity 90% and specificity 80%) and old-old subjects (cutoff 60; sensitivity 82% and specificity 100%).
CONCLUSIONS: The Italian ACE-R is a valid screening tool to detect dementia, especially in the old-old population, which represents not only the fastest growing age group but also the group at the highest risk of dementia in Western countries.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22262124     DOI: 10.1159/000334657

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  18 in total

1.  Dopamine agonists can improve pure apathy associated with lesions of the prefrontal-basal ganglia functional system.

Authors:  Carlo Blundo; Carmela Gerace
Journal:  Neurol Sci       Date:  2015-01-21       Impact factor: 3.307

2.  DMapp: a developing promising approach to monitor symptoms progression and stimulate memory in Italian people with cognitive impairments.

Authors:  Martina Pigliautile; Matteo Colombo; Teresa Pizzuti; Nicola Procopio; Maria Stillo; Rosario Curia; Patrizia Mecocci
Journal:  Aging Clin Exp Res       Date:  2022-08-29       Impact factor: 4.481

Review 3.  Psychometrics and diagnostics of Italian cognitive screening tests: a systematic review.

Authors:  Edoardo Nicolò Aiello; Sara Rimoldi; Nadia Bolognini; Ildebrando Appollonio; Giorgio Arcara
Journal:  Neurol Sci       Date:  2021-11-24       Impact factor: 3.830

4.  Normative data for the ACE-R in an Italian population sample.

Authors:  Martina Pigliautile; Francesca Chiesi; Sonia Rossetti; Manuela Conestabile Della Staffa; Monica Ricci; Stefano Federici; Dora Chiloiro; Caterina Primi; Patrizia Mecocci
Journal:  Neurol Sci       Date:  2015-07-28       Impact factor: 3.307

5.  The Addenbrooke's Cognitive Examination Revised (ACE-R) and its sub-scores: normative values in an Italian population sample.

Authors:  Mattia Siciliano; Simona Raimo; Dario Tufano; Giuseppe Basile; Dario Grossi; Franco Santangelo; Luigi Trojano; Gabriella Santangelo
Journal:  Neurol Sci       Date:  2015-11-12       Impact factor: 3.307

6.  Active elderly and health-can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial.

Authors:  Mauro Giovanni Carta; Giulia Cossu; Elisa Pintus; Rosanna Zoccheddu; Omar Callia; Giuliana Conti; Mirra Pintus; Cesar Ivan Aviles Gonzalez; Maria Valeria Massidda; Gioia Mura; Claudia Sardu; Paolo Contu; Luigi Minerba; Roberto Demontis; Massimiliano Pau; Gabriele Finco; Eleonora Cocco; Maria Petronilla Penna; Germano Orrù; Goce Kalcev; Federico Cabras; Stefano Lorrai; Andrea Loviselli; Fernanda Velluzzi; Marco Monticone; Enrico Cacace; Mario Musu; Franco Rongioletti; Alberto Cauli; Valeria Ruggiero; Alessandra Scano; Antonio Crisafulli; Sofia Cosentino; Laura Atzori; Elena Massa; Quirico Mela; Dario Fortin; Gianmario Migliaccio; Antonio Egidio Nardi; Matthias Angermeyer; Antonio Preti
Journal:  Trials       Date:  2021-05-07       Impact factor: 2.279

7.  Differential diagnosis of depression and Alzheimer's disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R).

Authors:  Augustinas Rotomskis; Ramunė Margevičiūtė; Arūnas Germanavičius; Gintaras Kaubrys; Valmantas Budrys; Albinas Bagdonas
Journal:  BMC Neurol       Date:  2015-04-17       Impact factor: 2.474

8.  Screening for Mild Cognitive Impairment in Parkinson's Disease: Comparison of the Italian Versions of Three Neuropsychological Tests.

Authors:  Angela Federico; Alice Maier; Greta Vianello; Daniela Mapelli; Michela Trentin; Giampietro Zanette; Alessandro Picelli; Marialuisa Gandolfi; Stefano Tamburin
Journal:  Parkinsons Dis       Date:  2015-11-08

9.  The Mini-Addenbrooke's Cognitive Examination: a new assessment tool for dementia.

Authors:  Sharpley Hsieh; Sarah McGrory; Felicity Leslie; Kate Dawson; Samrah Ahmed; Chris R Butler; James B Rowe; Eneida Mioshi; John R Hodges
Journal:  Dement Geriatr Cogn Disord       Date:  2014-09-11       Impact factor: 2.959

10.  Reporting of the translation and cultural adaptation procedures of the Addenbrooke's Cognitive Examination version III (ACE-III) and its predecessors: a systematic review.

Authors:  Nadine Mirza; Maria Panagioti; Muhammad Wali Waheed; Waquas Waheed
Journal:  BMC Med Res Methodol       Date:  2017-09-13       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.